Pfizer, AstraZeneca Deal Hopes Wilt After Inversion Rules
Friday marks one month since regulators loosened restrictions on AstraZeneca PLC reviving merger talks with Pfizer Inc., but a lack so far of apparent movement toward a deal and new U.S....To view the full article, register now.
Already a subscriber? Click here to view full article